Consolidated Income Statements - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenue
Service fees	$ 4,778,249	$ 4,167,858
Lease equipment sales	0	74,889
Finance lease revenue	47,707	75,415
Consulting revenue	0	8,310
Total revenue	4,825,956	4,326,472
Cost of sales	3,299,315	3,045,661
Gross profit	1,526,641	1,280,811
Selling, general and administrative expenses	2,600,745	3,026,754
Operating income (loss)	(1,074,104)	(1,745,943)
Other income and (expense)
Gain (loss) on investments in securities	(14,961)	(78,649)
Realized gain on sale of GlauCanna rights	31,000	0
Impairment of investments	(139,148)	(1,688,825)
Interest income	92,571	108,113
Interest expense	(35,295)	(22,596)
Gain (loss) on equipment disposal	67	2,200
Paycheck protection program loan forgiven	452,348	0
EIDL grant	10,000	0
Other income (expense)	10,031	21,896
Total other income and (expense)	406,613	(1,657,861)
Income (loss) before provision for income taxes	(667,491)	(3,403,804)
Provision for income taxes	10,050	14,828
Net Income (Loss)	(677,541)	(3,418,632)
Gain (loss) attributable to non-controlling interest	48,484	18,258
Net Income (Loss)	$ (726,025)	$ (3,436,890)
Earnings Per Share, Basic and Diluted
Earnings Per Share, Basic and Diluted	$ (0.032)	$ (0.149)
Weighted Average Number of Shares Outstanding, Basic and Diluted	22,850,947	23,117,615